A simple innovative spectrofluorometric method for the determination of alendronate in bulk and in pharmaceutical tablets
- 18 March 2019
- journal article
- research article
- Published by Wiley in Luminescence
- Vol. 34 (3) , 375-381
Abstract
Sodium alendronate is the first in a pharmacological class known as bisphosphonates, used for treatment of various bone diseases. Assay of bisphosphonates by a spectroscopic technique is very challenging due to the fact that they lack chromophores and none of them are fluorescent. In this work, a simple method is presented for determination of alendronate in bulk and in pharmaceutical tablets using spectrofluorometry by exploiting the ability of alendronate to displace salicylate from the iron(III)–salicylate chelate, forming a non‐fluorescent colorless iron(III)–alendronate complex. The liberated salicylate is fluorescent and is equivalent to the mount of alendronate added. The response was linear over the concentration range 20–90 μM and the proposed method was validated according to the guidelines of the International Conference on Harmonization. The correlation coefficient was found to be 0.995 and the limit of detection was 7.5 μM. The method was successfully applied for determination of alendronate in the commercially available Osteonate® tablets. The average percent recovery ± percent relative standard deviation was found to be 102.118 ± 2.033 which is congruent with the label claim of the dosage form. The results were also compared to a reported method using t‐test and F‐test at 95% confidence level; no significant differences were observed. The presented method is simple, fast, easy, cost‐effective and suitable for routine pharmaceutical analysis.Keywords
This publication has 25 references indexed in Scilit:
- Flow injection determination of carboxylate, phosphate, and sulfhydryl compounds using metal exchange complexationTalanta, 2012
- Spectrofluorimetric Determination of Alendronate by Conjugation with the Rhodamine B Sulfonyl GroupBulletin of the Korean Chemical Society, 2011
- Stability indicating ion chromatography method for the simultaneous determination of ibandronate sodium drug substance and its impuritiesJournal of Pharmaceutical and Biomedical Analysis, 2011
- Spectrofluorimetric Determination of Bisphosphonates in Biological Sample with a Fluorescent Chemosensor, NadDPA-2Zn2+Bulletin of the Korean Chemical Society, 2010
- Fluorescence Quenching of Norfloxacin by Divalent Transition Metal CationsBulletin of the Korean Chemical Society, 2007
- Normal spectrophotometric and stopped-flow spectrofluorimetric sequential injection methods for the determination of alendronic acid, an anti-osteoporosis amino-bisphosphonate drug, in pharmaceuticalsAnalytica Chimica Acta, 2005
- Spectroscopic and HPLC methods for the determination of alendronate in tablets and urineTalanta, 2004
- Determination of bisphosphonates by ion chromatography–inductively coupled plasma mass spectrometryJournal of Chromatography A, 2004
- Determination of the bisphosphonate pamidronate disodium in urine by pre-column derivatization with fluorescamine, high-performance liquid chromatography and fluorescence detectionJournal of Chromatography B: Biomedical Sciences and Applications, 1989
- Stability constants of three iron(III) salicylatesCanadian Journal of Chemistry, 1970